Dr. Pasquale W. Benedetto, MD
- Medicare services, 2024
- 147
- Medicare patients, 2024
- 83
- Part D claims, 2024
- 348
- Publications
- 49
- Clinical trials
- 3
- Practice address
- 1475 Nw 12th Ave, Miami, FL 33136
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Benedetto's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Pasquale W. Benedetto is a medical oncologist in Miami, Florida
Dr. Benedetto practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.
Dr. Benedetto's NPI, 1528095775, was assigned on June 26, 2006. Dr. Benedetto graduated from Weill Cornell Medicine in 1976. Dr. Benedetto holds Florida license ME41018.
- NPI
- 1528095775NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1557558707
- NPI enumeration date
- June 26, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 76
- Medical school graduation
- 1976
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Pasquale W. Benedetto practices at Sylvester Comprehensive Cancer Center in Miami, Florida
Dr. Benedetto's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.
- Sylvester Comprehensive Cancer Center1475 Nw 12th Ave, Miami, FL 33136
Source: Dmand AI Affiliation Data
Dr. Pasquale W. Benedetto is affiliated with 2 sites of care and 1 medical group
Dr. Benedetto's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Benedetto is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Pasquale W. Benedetto's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benedetto practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Sylvester Comprehensive Cancer Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Miami and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Pasquale W. Benedetto is one of 477 medical oncologists in Florida
Medical oncology is Dr. Benedetto's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Benedetto is board certified in hematology by the American Board of Internal Medicine. Dr. Benedetto is licensed in Florida.
Specialties and state licenses
- Medical oncology, FloridaPrimary
Clinical focus
Dmand AI lists multiple myeloma and prostate cancer among the conditions Dr. Benedetto treats.
Medical oncologists near Dr. Benedetto
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Pasquale W. Benedetto billed Medicare for 147 services in 2024
CMS data shows 147 Medicare services from Dr. Benedetto across 2 procedure codes in 2024, all of them office visits, for 83 Medicare patients. Medicare paid $10,289 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Benedetto's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1712024: 14714%
Dr. Benedetto compared with the Florida median for medical oncologists, 2024
- Dr. Benedetto
- Florida median
- Medicare services
- 147vs 19,75599% below
- Medicare patients
- 83vs 54185% below
- Part D claims
- 99vs 59883% below
Medians across 462 medical oncologists in Florida with Dmand AI profiles that report each measure.
Dr. Benedetto's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Benedetto?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Benedetto and other medical oncologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Pasquale W. Benedetto treated 83 Medicare patients in 2024, average age 72
CMS counts 83 Medicare patients who saw Dr. Benedetto in 2024. The largest group is 65 to 74, with 34 patients. 73% of them have high blood pressure, and 70% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Benedetto's median patient age at 60, with 27% women.
Dr. Benedetto's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Benedetto's Medicare patients by sex, 2024
- Women2125%
- Men6275%
Chronic conditions among Dr. Benedetto's Medicare patients, 2024
- High blood pressure73%
- High cholesterol70%
- Cancer55%
- Arthritis45%
- Chronic kidney disease43%
- Ischemic heart disease37%
- Diabetes31%
- Anxiety22%
Share of Medicare patients with each condition. A patient can have several.
Dr. Benedetto's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 60
Patient panel by sex, all payers
- Women27%
- Men72%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Pasquale W. Benedetto wrote 348 Medicare Part D claims in 2024
In 2024, Dr. Benedetto wrote 348 Medicare Part D claims for 38 patients. 72% of them were for generic drugs. CMS names the drug for 99 of them, across 6 drugs with 11 or more claims each, at $721,908 in total drug cost. In 2023, CMS named 100 claims across 6 drugs.
Dr. Benedetto's Part D claims by kind of drug, 2024
- Generic252 claims72%
- Brand-name96 claims28%
Dr. Benedetto's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Benedetto's Part D claims, 2024
- Opioids7%26 of 348 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1002024: 991%
Drugs named by CMS: 6 in 2024, 6 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Pasquale W. Benedetto scored 88 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Benedetto for performance year 2024, reported as part of a group. Dr. Benedetto accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Benedetto's MIPS scores, performance year 2024
- 88of 100Final score
- 78.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 71of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Pasquale W. Benedetto has 49 publications on record
Dmand AI links 49 papers to Dr. Benedetto, published from 2012 to 2025. 2012 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Doxorubicin and Carcinoma, Adenoid Cystic. Dr. Benedetto has published most often in Am J Clin Oncol. Dr. Benedetto's most frequent co-authors are Lynn G. Feun, MD, David T. Tse, MD and Bach Ardalan, MD.
Dr. Benedetto's papers by year, 2012 to 2025
Topics Dr. Benedetto writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Doxorubicin
- Carcinoma, Adenoid Cystic
- Eye Neoplasms
- Lacrimal Apparatus Diseases
- Cisplatin
- Drug Evaluation
- Infusions, Intra-Arterial
Dr. Benedetto's most frequent co-authors
Recent publications by Dr. Benedetto
See who Dr. Benedetto researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Benedetto works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Pasquale W. Benedetto has worked on 3 clinical trials
Dmand AI links Dr. Benedetto to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Bone Neoplasms, Lymphatic Metastasis and Sarcoma.
Clinical trials with Dr. Benedetto by phase
- 1Phase 1: 1 trial
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Benedetto's trials
- Bone Neoplasms
- Lymphatic Metastasis
- Sarcoma
- Bone Diseases
- Carcinoma, Renal Cell
Investigators on the most trials with Dr. Benedetto
- Nabil Adra, MD1 shared trial
- Shahid Sattar Ahmed, MBBS1 shared trial
- Harish Gangaram Ahuja, MD1 shared trial
Recent clinical trials with Dr. Benedetto
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study (opens in a new tab)
Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Pasquale W. Benedetto received $13,584 in industry payments from 2016 to 2025
CMS Open Payments shows 229 general payments to Dr. Benedetto from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. Novartis Pharmaceuticals Corporation paid the most, $8,112.
General payments to Dr. Benedetto by program year, 2016 to 2025
General payments to Dr. Benedetto by kind, 2016 to 2025
- Consulting fees$7,73057%
- Food and beverage$4,49733%
- Travel and lodging$1,2459%
- Education$1131%
Companies that paid Dr. Benedetto the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Pasquale W. Benedetto has 6 awards and honors on record
Dmand AI lists 6 awards for Dr. Benedetto, most recently America's Top Doctors in 2014.
Awards and honors for Dr. Benedetto
- 2014
- America's Top Doctors
- 2013
- America's Top Doctors for Cancer
- CMS Stage 1 EHR
- 2012
- Top Doctors:South Florida
- 2000
- Top Doctors: Florida
- Undated
- Super Doc
Source: Dmand AI Professional Profile Data
Dr. Pasquale W. Benedetto graduated from Weill Cornell Medicine
Dr. Benedetto graduated from Weill Cornell Medicine in 1976. Dr. Benedetto is a member of ASCO.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Pasquale W. Benedetto accepts plans from 11 insurance carriers
Dr. Benedetto is in network with 11 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.
- Elevance
- Aetna
- United Healthcare
- Blue Cross Blue Shield of Michigan
- Molina
- Aspirus Health Plan
- Blue Cross and Blue Shield of Kansas City
- Cigna
- +3 more carriersWith a free account
Plan types Dr. Benedetto accepts, by number of carriers
- PPO7
- HMO5
- Medicare5
- POS5
- EPO3
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Pasquale W. Benedetto's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Pasquale W. Benedetto
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Pasquale W. Benedetto's NPI number?
Dr. Pasquale W. Benedetto's NPI number is 1528095775. It was assigned on June 26, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Pasquale W. Benedetto?
Dr. Pasquale W. Benedetto is a medical oncologist in Miami, Florida. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Pasquale W. Benedetto practice?
Dr. Benedetto practices at 1475 Nw 12th Ave, Miami, FL 33136. Dr. Benedetto's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.
What is Dr. Pasquale W. Benedetto's medical license number?
Dr. Benedetto holds Florida license ME41018.
Which hospitals is Dr. Pasquale W. Benedetto affiliated with?
Dr. Benedetto practices at Sylvester Comprehensive Cancer Center in Miami, Florida. Dr. Benedetto is also affiliated with Jackson Memorial Hospital.
What medical group is Dr. Pasquale W. Benedetto part of?
Dr. Benedetto is linked to University of Miami Health System.
Does Dr. Pasquale W. Benedetto accept Medicare?
Yes. CMS data shows Dr. Benedetto billed Medicare for 147 services in 2024, and Dr. Benedetto accepts Medicare assignment.
What is Dr. Pasquale W. Benedetto's MIPS score?
Dr. Benedetto's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.
How many Medicare patients does Dr. Pasquale W. Benedetto see?
CMS counts 83 Medicare patients who saw Dr. Benedetto in 2024, with an average age of 72.
Is Dr. Pasquale W. Benedetto board certified?
Yes. Dr. Benedetto is board certified in hematology by the American Board of Internal Medicine.
Show 8 more questionsShow fewer questions
What services does Dr. Pasquale W. Benedetto bill to Medicare?
In 2024, Dr. Benedetto's most billed Medicare services were office visit, established patient (99214) and office visit, established patient (99213).
Where did Dr. Pasquale W. Benedetto go to medical school?
Dr. Benedetto graduated from Weill Cornell Medicine in 1976.
What drugs does Dr. Pasquale W. Benedetto prescribe most?
In 2024 Medicare Part D data, Dr. Benedetto's most prescribed drugs by claims were Cabometyx, Sunitinib Malate and Alprazolam.
Has Dr. Pasquale W. Benedetto received payments from drug or device companies?
CMS Open Payments shows $13,584 in general payments to Dr. Benedetto from 27 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Pasquale W. Benedetto been practicing?
Dr. Benedetto graduated from medical school in 1976, 50 years ago.
Does Dr. Pasquale W. Benedetto do research?
Dmand AI links 49 publications to Dr. Benedetto, published from 2012 to 2025. Dr. Benedetto has worked on 3 clinical trials.
Who does Dr. Pasquale W. Benedetto publish with?
Dr. Benedetto's most frequent co-authors are Lynn G. Feun, MD (11 shared papers), David T. Tse, MD (9 shared papers) and Bach Ardalan, MD (7 shared papers).
What insurance does Dr. Pasquale W. Benedetto accept?
Dr. Benedetto is in network with 11 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card